Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028


Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Key Highlights

  • The G8 countries contributed $882.6 billion in 2023 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.8% between 2019 and 2023. The G8 countries are expected to reach a value of $1,038.8 billion in 2028, with a CAGR of 3.3% over the 2023-28 period.
  • Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $496.7 billion in 2023. This was followed by Japan and Germany, with a value of $94.3 and $87.2 billion, respectively.
  • The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $579.7 billion in 2016, followed by Germany and Japan with expected values of $113.9 and $104.5 billion, respectively.




Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country




Reasons To Buy

  • What was the size of the G8 pharmaceuticals market by value in 2023?
  • What will be the size of the G8 pharmaceuticals market in 2028?
  • What factors are affecting the strength of competition in the G8 pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the G8 pharmaceuticals market?